30 Sept 2026, 11:07
Securities Administration—
PTXPRESCIENT THERAPEUTICS LIMITED
Announcement history available from 1 August 2025
Fromto
30 Sept 2026, 09:49
Securities Administration—
30 Sept 2026, 09:45
Securities Administration—
30 Sept 2026, 09:44
Securities Administration—
23 Sept 2026, 10:04
Securities Administration—
23 Sept 2026, 10:03
Capital RaisingMS
21 Sept 2026, 09:33
Trading Halt / SuspensionMS
15 Sept 2026, 11:54
Securities Administration—
15 Sept 2026, 09:00
Capital RaisingMS
14 Sept 2026, 09:10
Presentations—
8 Sept 2026, 09:18
Securities Administration—
8 Sept 2026, 09:03
Capital RaisingMS
2 Sept 2026, 14:10
Company UpdateMS
26 Aug 2026, 09:53
Capital Raising—
26 Aug 2026, 08:57
Capital RaisingMS
26 Aug 2026, 08:45
Securities Administration—
25 Aug 2026, 14:47
Securities Administration—
25 Aug 2026, 09:06
Capital RaisingMS
21 Aug 2026, 09:34
Company Administration—
21 Aug 2026, 09:32
Financial ResultsMS
27 July 2026, 12:36
Quarterly ReportsMS
10 July 2026, 14:53
Securities Administration—
11 June 2026, 10:03
Presentations—
15 May 2026, 09:01
ASX QueryMS
30 Apr 2026, 09:37
Presentations—
30 Apr 2026, 09:25
Quarterly ReportsMS
25 Feb 2026, 09:03
Company Administration—
24 Feb 2026, 17:00
Financial ResultsMS
30 Jan 2026, 09:16
Quarterly ReportsMS
19 Dec 2025, 13:18
Securities Administration—
15 Dec 2025, 09:10
Company UpdateMS
21 Nov 2025, 10:03
Director Interests—
21 Nov 2025, 10:02
Director Interests—
21 Nov 2025, 10:01
Director Interests—
21 Nov 2025, 10:00
Director Interests—
21 Nov 2025, 09:57
Director Interests—
19 Nov 2025, 09:02
Company UpdateMS
18 Nov 2025, 10:25
Securities Administration—
28 Oct 2025, 14:34
Securities Administration—
14 Oct 2025, 16:42
Meetings & Governance—
14 Oct 2025, 10:43
Presentations—
10 Oct 2025, 09:07
Quarterly ReportsMS
12 Sept 2025, 10:54
Meetings & Governance—
1 Sept 2025, 17:04
Securities Administration—
29 Aug 2025, 11:37
Securities Administration—
29 Aug 2025, 11:34
Securities Administration—
20 Aug 2025, 16:30
Company Administration—
20 Aug 2025, 16:29
Financial ResultsMS
12 Aug 2025, 09:34
Capital Raising—
12 Aug 2025, 09:31
Securities Administration—
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 30 Sept 2026, 11:07 | Notification regarding unquoted securities - PTX | Securities Administration | — | 06021 | |
| 30 Sept 2026, 09:49 | Section 708A Cleansing Notice | Securities Administration | — | 06018 | |
| 30 Sept 2026, 09:45 | Application for quotation of securities - PTX | Securities Administration | — | 06020 | |
| 30 Sept 2026, 09:44 | Application for quotation of securities - PTX | Securities Administration | — | 06020 | |
| 23 Sept 2026, 10:04 | Proposed issue of securities - PTX | Securities Administration | — | 06013 | |
| 23 Sept 2026, 10:03 | PTX Successfully Completes $6m Raise Via SPP and Placement | Capital Raising | MS | 06003, 06017, 09014 | |
| 21 Sept 2026, 09:33 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 15 Sept 2026, 11:54 | Update - Proposed issue of securities - PTX | Securities Administration | — | 06013 | |
| 15 Sept 2026, 09:00 | Prescient Therapeutics - Extension of Share Purchase Plan | Capital Raising | MS | 06017, 14014 | |
| 14 Sept 2026, 09:10 | Notice of Annual General Meeting/Proxy Form | Presentations | — | 08001, 08004, 14014 | |
| 8 Sept 2026, 09:18 | Update - Proposed issue of securities - PTX | Securities Administration | — | 06013 | |
| 8 Sept 2026, 09:03 | Prescient Therapeutics - Extension of Share Purchase Plan | Capital Raising | MS | 06017, 14014 | |
| 2 Sept 2026, 14:10 | PTX-100 CTCL Phase 2a study reaches review milestone | Company Update | MS | 11001, 14014 | |
| 26 Aug 2026, 09:53 | Prescient Share Purchase Plan Investor Presentation | Capital Raising | — | 03026, 06017 | |
| 26 Aug 2026, 08:57 | Prescient Therapeutics Opens SPP to Raise $7m Today | Capital Raising | MS | 06017, 14014, 16002 | |
| 26 Aug 2026, 08:45 | Share Purchase Plan Cleansing Notice | Securities Administration | — | 06018 | |
| 25 Aug 2026, 14:47 | Proposed issue of securities - PTX | Securities Administration | — | 06013 | |
| 25 Aug 2026, 09:06 | Prescient Therapeutics Launches Share Purchase Plan for $7m | Capital Raising | MS | 06017, 14014 | |
| 21 Aug 2026, 09:34 | Appendix 4G and Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 21 Aug 2026, 09:32 | Appendix 4E and 2026 Annual Report | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 | |
| 27 July 2026, 12:36 | June 2026 Quarterly Update and Appendix 4C | Quarterly Reports | MS | 14014, 19004, 19009 | |
| 10 July 2026, 14:53 | Notification of cessation of securities - PTX | Securities Administration | — | 06027 | |
| 11 June 2026, 10:03 | PTX Dr Rosalind Wilson appointed as Chief Medical Officer | Presentations | — | 12008, 14014 | |
| 15 May 2026, 09:01 | Response to ASX Price Query | ASX Query | MS | 17003 | |
| 30 Apr 2026, 09:37 | Investor Presentation | Presentations | — | 03026 | |
| 30 Apr 2026, 09:25 | March 2026 Quarterly Update and Appendix 4C | Quarterly Reports | MS | 19003, 19008 | |
| 25 Feb 2026, 09:03 | Updated Securities Trading Policy | Company Administration | — | 14013 | |
| 24 Feb 2026, 17:00 | Appendix 4D and Half Year Financial Report | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 30 Jan 2026, 09:16 | December 2025 Quarterly Update and Appendix 4C | Quarterly Reports | MS | 14014, 19002, 19007 | |
| 19 Dec 2025, 13:18 | Notification regarding unquoted securities - PTX | Securities Administration | — | 06021 | |
| 15 Dec 2025, 09:10 | PTX secures EU Authorisation to commence PTX-100 Trial | Company Update | MS | 11001 | |
| 21 Nov 2025, 10:03 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 21 Nov 2025, 10:02 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 21 Nov 2025, 10:01 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 21 Nov 2025, 10:00 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 21 Nov 2025, 09:57 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 19 Nov 2025, 09:02 | PTX secures EU Orphan Drug Designation for PTX-100 in CTCL | Company Update | MS | 11001, 14014 | |
| 18 Nov 2025, 10:25 | Notification regarding unquoted securities - PTX | Securities Administration | — | 06021 | |
| 28 Oct 2025, 14:34 | Amended Constitution | Securities Administration | — | 12012 | |
| 14 Oct 2025, 16:42 | Results of Annual General Meeting | Meetings & Governance | — | 08003 | |
| 14 Oct 2025, 10:43 | Chair Address and CEO AGM Presentation | Presentations | — | 03026, 15002 | |
| 10 Oct 2025, 09:07 | September Quarterly Updated and Appendix 4C | Quarterly Reports | MS | 19001, 19006 | |
| 12 Sept 2025, 10:54 | Notice of Annual General Meeting/Proxy Form | Meetings & Governance | — | 08001, 08004 | |
| 1 Sept 2025, 17:04 | Notification regarding unquoted securities - PTX | Securities Administration | — | 06021 | |
| 29 Aug 2025, 11:37 | Completion of Share Placement & s708A Cleansing Notice | Securities Administration | — | 06018 | |
| 29 Aug 2025, 11:34 | Application for quotation of securities - PTX | Securities Administration | — | 06020 | |
| 20 Aug 2025, 16:30 | Appendix 4G and Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 20 Aug 2025, 16:29 | Appendix 4E and 2025 Annual Report | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 | |
| 12 Aug 2025, 09:34 | Share Placement Progress and Cleansing Notice | Capital Raising | — | 06003, 06018 | |
| 12 Aug 2025, 09:31 | Application for quotation of securities - PTX | Securities Administration | — | 06020 |
1–50 of 53
1 / 2